SPY369.85+3.16 0.86%
DIA302.59+2.53 0.84%
IXIC12,464.23+87.05 0.70%

RAPT Therapeutics Q3 EPS $(0.60) Up From $(12.41) YoY, Sales $1.53M

RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.60) per share. This is a 95.17 percent increase over losses of $(12.41) per share from the same period last year. The company reported $1.53 million in

· 11/16/2020 08:20
RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.60) per share. This is a 95.17 percent increase over losses of $(12.41) per share from the same period last year. The company reported $1.53 million in sales this quarter.